Mesenchymal stromal cell-laden hydrogels in tissue regeneration: insights from preclinical and clinical research
Authors:
Open Access
- 12 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1670649
Abstract
Hydrogel-based delivery systems have emerged as a promising strategy to enhance the therapeutic efficacy of mesenchymal stromal cells (MSCs) in regenerative medicine. These biomimetic platforms provide a three-dimensional microenvironment that recapitulates key features of native extracellular matrix, supporting MSC viability, retention, and function upon transplantation. Beyond acting as passive carriers, hydrogels can be engineered with tunable biochemical and mechanical properties to modulate MSC behavior, including their differentiation potential, immunomodulatory activity, and paracrine signaling. Recent advances include the development of “smart” hydrogels responsive to physiological stimuli, enabling controlled release of encapsulated cells or bioactive molecules in response to local cues. Preclinical studies have demonstrated enhanced tissue repair in diverse pathological contexts, including musculoskeletal, cardiovascular, gastrointestinal, dermal, and neural injuries. Importantly, translation to clinical settings is being facilitated by the use of xeno-free, good manufacturing practices (GMP)-compliant components such as platelet derivatives and synthetic polymers. Selected early-phase clinical trials support the feasibility, safety, and therapeutic potential of MSC-laden hydrogels, although further studies are required to optimize delivery parameters and regulatory compliance. This review summarizes current progress in hydrogel-MSC systems across application areas, emphasizing design principles, preclinical outcomes, and translational challenges, with the aim of guiding future developments in stem cell-based tissue regeneration.Keywords
This publication has 85 references indexed in Scilit:
- Therapeutic Performance of Hydrogel‐Derived Extracellular Wharton's Jelly Matrix and Wharton's Jelly Mesenchymal Stem Cells in Repairing Infarcted Myocardium of Ischemic Rats: a Preclinical StudyMacromolecular Bioscience, 2025
- Effects of Hydrogels on Mesenchymal Stem/Stromal Cells Paracrine Activity and Extracellular Vesicles ProductionJournal of Extracellular Vesicles, 2025
- Hydrogels for Nucleic Acid Drugs DeliveryAdvanced Healthcare Materials, 2024
- Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart DiseaseJAMA Network Open, 2020
- Injectable BMP-2 gene-activated scaffold for the repair of cranial bone defect in miceStem Cells Translational Medicine, 2020
- Bionic Detectors Based on Low‐Bandgap Inorganic Perovskite for Selective NIR‐I Photon Detection and ImagingAdvanced Materials, 2019
- Adhesive Hemostatic Conducting Injectable Composite Hydrogels with Sustained Drug Release and Photothermal Antibacterial Activity to Promote Full‐Thickness Skin Regeneration During Wound HealingSmall, 2019
- Biocompatibility and preclinical feasibility tests of a temperature‐sensitive hydrogel for the purpose of surgical wound pain control and cartilage repairJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2013
- Sustained delivery of bioactive TGF‐β1 from self‐assembling peptide hydrogels induces chondrogenesis of encapsulated bone marrow stromal cellsJournal of Biomedical Materials Research Part A, 2013
- Fabrication of poly(lactide‐co‐glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)‐b‐poly(L‐lysine)/TGF‐β1 plasmid DNA complexes for cartilage restoration in vivoJournal of Biomedical Materials Research Part A, 2013